Is EFX a good stock to buy?
Equifax Inc. · end-of-day data as of Nov 13, 2026
- PT$200.88 +6.8%
- ConsensusBuy · 24
- FCF yield+5.0%
- MAs4 of 4
- MA20×50Golden 8d ago
- Earnings in82d
- P/E30.4x
- RSI62
- Support-0.7%
- Resistance+3.7%
- Off 52w high-17.7%
- Volume0.4x
- Bollingerupper half
- News0.00
- P/E vs own-0.8%
- Trendsideways
- 52w range$137–$229
- ATR+3.1%
- Off ATH-39.2%
- P/E vs sector+11.0%
- Insiders-$11.33M
- MACD-0.37
- Sector▼ -11.7%
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Equifax a good stock to buy?
Equifax is strong on 2 of the 5 questions about the business. The price is low: 30.4 times its earnings, below its 3-year median of 50.3 (Nov 13, 2026). pretickt does not say whether to buy or sell.
- Demand steady
- Advantage some edge
- Economics profitable
- Execution delivers
- Fragility sturdy
- Price below its usual
EFX sales growth revenue growth
+6%a year, for the last 3 yearsEquifax's sales grew 6% a year for 3 years, to $6.07B in fiscal 2025.
EFX analysts' forecast revenue estimates
+10%the sales they expect next fiscal year, on the lastAnalysts expect Equifax's sales to grow 10% to $6.67B in fiscal 2026 (16 analysts).
EFX peers
pretickt analysis+11%its sales in 12 months, on a year before
Equifax's sales grew 11% in the 12 months to Sep 30, 2026, faster than J.B. Hunt (+11%) and Xylem (+2%), slower than Symbotic (+21%) and Southwest Airlines (+15%).
EFX sales by business revenue by segment
43%of its sales from Workforce SolutionsWorkforce Solutions brought Equifax 43% of its sales in fiscal 2025; U.S. Information Solutions 34%.
EFX return on capital ROIC
pretickt analysis13%earned before tax on the money invested in itEquifax earned 13% before tax on the capital invested in it in the 12 months to Sep 30, 2026; J.B. Hunt 20%, Southwest Airlines 13% and Xylem 11%.
EFX margin on each sale gross margin
55%left after making the productEquifax kept 55% of each sale after making the product in the 12 months to Sep 30, 2026; its peers' median is 31%.
EFX margin after costs profit margin
19%of sales left after running the businessEquifax's operating margin was 19% in the 12 months to Sep 30, 2026, against 21% in fiscal 2022.
EFX cash generated free cash flow
$1.1Bcash left after investing, last 12 monthsEquifax generated $1.1B of free cash flow in the 12 months to Sep 30, 2026, more than its reported profit.
EFX earnings vs estimates
7 of 8quarters above the analysts' estimateEquifax beat the analysts' profit estimate in 7 of its last 8 quarters, the latest on Oct 20, 2026.
EFX insider selling
-$35.9Msold, net, by its executives in 12 monthsEquifax's executives and directors sold a net $35.9M of shares in the 12 months to Nov 13, 2026 ($36.37M sold, $465K bought).
EFX number of employees
+2%more people in a yearEquifax had 15,000 employees at the end of fiscal 2025, 2% more than a year before.
EFX CEO pay
$23.42Mfor fiscal 2025, 79% of it in stock and optionsEquifax paid its CEO $23.42M for fiscal 2025, 79% of it in stock and options.
EFX financial health Altman Z-score
3.5Altman Z-score, safe above 3Equifax's Altman Z-score is 3.5 (Nov 13, 2026), above 3, where the safe zone starts.
EFX quality checks Piotroski score
7 of 9checks passedEquifax passes 7 of the 9 Piotroski checks in the 12 months to Sep 30, 2026; it misses on long-term debt and gross margin.
EFX biggest customers
under 10%of sales from any one customerNo customer made 10% of Equifax's sales in fiscal 2025.
EFX in past recessions
pretickt analysis-11%its sales in the worst oneEquifax's sales fell in 1 of the last 2 US recessions, by as much as 11% in fiscal 2009.
EFX price vs profit P/E ratio
30.4×a year's earningsEquifax's P/E ratio is 30.4 (Nov 13, 2026), below its 3-year median of 50.3.
EFX price vs peers
pretickt analysis30.4×a year's earnings, against its peersInvestors pay 30.4 times Equifax's earnings (Nov 13, 2026), more than for Southwest Airlines (21.6) and Xylem (20.8), less than for Symbotic (376.1) and J.B. Hunt (32.7).
EFX analysts' target price target
+7%to their average targetAnalysts' average price target for Equifax is $201, 7% above the Nov 13, 2026 close of $188.12.
EFX analyst ratings, 90 days
pretickt analysisRothschild & Coupgrade Oppenheimerdowngrade Argus Researchupgrade RBC Capitaldowngrade
In the 90 days to Nov 13, 2026, Rothschild & Co and Argus Research upgraded Equifax; Oppenheimer and RBC Capital downgraded it.
EFX growth priced in fair value
pretickt analysis+7%a year, for ten years, to be worth the priceAt $188.12 a share, Equifax's free cash flow must grow about 7% a year for ten years to be worth the price (Nov 13, 2026).
What is Equifax's P/E ratio?
Equifax's P/E ratio is 30.4 (Nov 13, 2026), below its 3-year median of 50.3. Investors pay 30.4 times Equifax's earnings (Nov 13, 2026), more than for Southwest Airlines (21.6) and Xylem (20.8), less than for Symbotic (376.1) and J.B. Hunt (32.7).
Is Equifax profitable?
Equifax's operating margin was 19% in the 12 months to Sep 30, 2026, against 21% in fiscal 2022. Equifax generated $1.1B of free cash flow in the 12 months to Sep 30, 2026, more than its reported profit.
Are insiders selling Equifax stock?
Equifax's executives and directors sold a net $35.9M of shares in the 12 months to Nov 13, 2026 ($36.37M sold, $465K bought).
How does Equifax make money?
Workforce Solutions brought Equifax 43% of its sales in fiscal 2025; U.S. Information Solutions 34%.
How many employees does Equifax have?
Equifax had 15,000 employees at the end of fiscal 2025, 2% more than a year before.
Who are Equifax's biggest customers?
No customer made 10% of Equifax's sales in fiscal 2025.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.